Null
Extracorporeal Membrane Oxygenation Machine Market

Report ID: SQMIG35A3132

sales@skyquestt.com
USA +1 351-333-4748

Extracorporeal Membrane Oxygenation Machine Market Size, Share, and Growth Analysis

Null

Extracorporeal Membrane Oxygenation Machine Market By Component (Pumps, Oxygenators), By Modality (Veno-Venous (VV), Veno-Arterial (VA)), By Patient Age Group (Neonates, Pediatrics), By Application (Respiratory Disorders, Cardiac Conditions), By End-User, By Region - Industry Forecast 2026-2033


Report ID: SQMIG35A3132 | Region: Global | Published Date: January, 2026
Pages: 197 |Tables: 95 |Figures: 69

Format - word format excel data power point presentation

Extracorporeal Membrane Oxygenation Machine Market Insights

Global Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 328.22 Million in 2024 and is poised to grow from USD 345.94 Million in 2025 to USD 526.9 Million by 2033, growing at a CAGR of 5.4% during the forecast period (2026–2033).

The extracorporeal membrane oxygenation machine market is growing slowly as this life-saving technology becomes a more critical aspect of the management of severe cardiac and respiratory failure, especially when traditional treatments are ineffective. Demand for this market is driven by advancements in critical care infrastructure, an increase in cardiopulmonary disease, and an increasing acceptance of ECMO in a clinical setting.

New ECMO technologies will include greater portability, biocompatible materials, integrated monitoring systems, and ergonomic and user-friendly designs suitable for use in emergency and transportation situations. An increased focus on the establishment of ECMO centers and trained multi-disciplinary teams in the hospital setting is facilitating even greater adoption of ECMO. Also, for acute respiratory infectious diseases, experience from the recent disease outbreaks have further underscored ECMO as an intervention leading an increasing number of hospitals to invest in this technology as part of their overall preparedness plans.

There are also challenges to address when looking at the market, including the high costs of both machines and consumables, the limited number of available trained professionals, and the complexities around managing ECMO procedures, which limits the use to large, tertiary care hospital sites. Also, reimbursement uncertainties and regulatory criteria can slow entry to the market, particularly in emerging economies.

How is AI Enhancing Monitoring and Automation in ECMO Systems?

Artificial intelligence (AI) is progressively changing the extracorporeal membrane oxygenation machine field, enhancing decision-making, clinical efficiency, and ultimately patient outcomes. Clinical decision support systems being highly utilized contain AI models to predict patient eligibility for ECMO support, define timing for ECMO initiation, and predict survival. Clinicians can have faster and improved decision-making in patient care through these tools. Machine learning algorithms can analyze large datasets of patients' HR, lab values, and hemodynamics in real time to intervene sooner and personalize the management of individual patients.

  • In 2024 multiple published developments outline the trend, the ECMO PAL model demonstrated improved predictive ability of patient survival using global registry data over traditional risk scores. Moreover, the CEVVO deep learning model was introduced to determine readiness for decannulation in patients on veno-venous ECMO to reduce the risk of early decannulation. These developments highlight their incorporation into critical care systems with predictive analytics.

Market snapshot - 2026-2033

Global Market Size

USD 311.4 million

Largest Segment

Veno-Venous (VV) ECMO

Fastest Growth

Veno-Arterial (VA) ECMO

Growth Rate

5.4% CAGR

Global Extracorporeal Membrane Oxygenation Machine Market ($ Mn) 2026-2033
Country Share for North America Region 2025 (%)

To get more insights on this market click here to Request a Free Sample Report

Extracorporeal Membrane Oxygenation Machine Market Segments Analysis

Global Extracorporeal Membrane Oxygenation Machine Market is segmented by Component, Modality, Patient Age Group, Application, End-User and region. Based on Component, the market is segmented into Pumps, Oxygenators, Controllers, Cannula & Tubing Sets and Accessories & Consumables. Based on Modality, the market is segmented into Veno-Venous (VV), Veno-Arterial (VA) and Arterio-Venous (AV). Based on Patient Age Group, the market is segmented into Neonates, Pediatrics and Adults. Based on Application, the market is segmented into Respiratory Disorders, Cardiac Conditions and Extracorporeal Cardiopulmonary Resuscitation (ECPR). Based on End-User, the market is segmented into Hospitals (ICU / Cardiac Care Units), Specialty Clinics and Emergency Medical Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Why are ECMO Systems Dominant in the Global Extracorporeal Membrane Oxygenation Machine Market?

As per global extracorporeal membrane oxygenation machine market analysis, ECMO systems are the Foundation of the ECMO therapeutic setups encompassing components or units such as the pump, oxygenator and console. These systems have a stronghold over the marketplace as hospitals, and critical care centers, prefer to have complete, consolidated, and integrated systems to deliver life-support therapy. The importance of ECMO systems is evident in the treatment of severe cardiac and respiratory failure, and they have entered the standard-of-care practices of tertiary hospitals, research centers, and specialist ICU's.

ECMO consumables segment is the fastest-growing segment in the market. The increasing demand for consumables correlates directly with the increase in ECMO procedures worldwide. This increase was facilitated by the second-wave incidence of ARDS. Further increase in demand for consumables can be attributed to improvements in biocompatible materials, disposable devices/systematics adopted in the developing global markets.

Why is Veno-Venous (VV) ECMO Leading the Global Extracorporeal Membrane Oxygenation Machine Market?

As per global extracorporeal membrane oxygenation machine market outlook, veno-venous (VV) ECMO is leading the market because it is mainly utilized for respiratory support, which makes up the majority of ECMO cases. Critical conditions in patients requiring ECMO include ARDS, pneumonia, and respiratory failure from infections, which are all addressed with VV ECMO. VV ECMO is appreciated for respiratory support because it has a better risk profile than VA ECMO and is easier to manage in critical care settings.

As per global extracorporeal membrane oxygenation machine market forecast, veno-arterial (VA) ECMO is the fastest growing segment. The growth in VA ECMO is being fueled by the rising prevalence of cardiovascular disease and the newly developed portable valves for VA ECMO. This discovery allows VA ECMO to be widely utilized in emergency and transport situations. There are also significant advancements in monitoring and automation that drive VA ECMO to better clinical outcomes, making VA ECMO an increasingly favorable intervention in high-risk situations.

Global Extracorporeal Membrane Oxygenation Machine Market By Type of ECMO 2026-2033 (%)

To get detailed segments analysis, Request a Free Sample Report

Extracorporeal Membrane Oxygenation Machine Market Regional Insights

What is the Forecasted Outcome for the Market in North America?

A high prevalence of cardiopulmonary conditions and significant investments in critical care technologies North America continues to remain a formidable region within the market. Hospitals in the region are progressively taking up ECMO systems to improve outcomes for patients with severe respiratory failure and cardiac failure. Furthermore, the market in North America continues to expand steadily due to continued innovation and clinical uptake.

Extracorporeal Membrane Oxygenation Machine Market in the U.S.

As per regional forecast, the United States is the frontrunner in ECMO utilization in North America, where ECMO systems are increasingly adopted into tertiary care hospitals and specialty intensive care units. The upward trend of the market is strongly supported by continuous advancements in technology, training programs for healthcare practitioners, and awareness of the clinical advantages of ECMO systems.

Extracorporeal Membrane Oxygenation Machine Market in Canada

As per regional outlook, the market in Canada is increasing due to hospital modernization of its critical care units and adoption of life supporting technologies. Provincial government support for advanced health care, in combination with increased training efforts, increases ECMO utilization nationally.

What is the Market Outlook for ECMO Machines in Asia-Pacific?

Consumers in the Asia-Pacific region are analyzing this dynamically developing area as an emerging high-growth market, driven by rising incidences of cardiopulmonary disease, growth of the healthcare system, and increased awareness of advanced life support therapies. Hospitals are investing in modern ECMO machines to strengthen clinical performance for patient treatment in an intensive care unit.

Extracorporeal Membrane Oxygenation Machine Market in Japan

Japan is the leader in ECMO in the Asia-Pacific region, with hospitals adding advanced medical technology and a well-trained staff. The development and purchase of medical equipment and an increasing clinical expertise will also be coupled with more government investment and support in critical care, and this will propel the market.

Extracorporeal Membrane Oxygenation Machine Market in South Korea

The South Korea market will develop as a function of having a combination of technological development, expanding the healthcare system, and focusing on delivering the best critical care. Joint projects from hospitals and device manufacturers can be expected, and this will lead to wider adoption of ECMO machine technology in hospitals throughout South Korea.

What is the Extracorporeal Membrane Oxygenation Machine Market Outlook in Europe?

In Europe, the market continues to see steady growth, supported by well-established healthcare systems, supportive government healthcare initiatives, and increased public awareness of the life-saving potential of ECMO therapy.

Extracorporeal Membrane Oxygenation Machine Market in Germany

As per industry analysis, Germany is leading the European market due to its widespread network of advanced hospitals, a strong focus on medical research, and a high uptake of advanced life-support technology. The regulatory infrastructure in Germany allows for the rapid uptake of new medical devices, and ongoing clinical research leads to better ECMO outcomes.

Extracorporeal Membrane Oxygenation Machine Market in the UK

The UK's market is strongly driven by the National Health Service (NHS), which supports the uptake of advanced life-support technology. Hospitals work collaboratively with medical device manufacturers to integrate innovative ECMO systems, and hospitals also provide continuous professional development programs to keep clinicians updated on the latest approaches.

Extracorporeal Membrane Oxygenation Machine Market in Italy

Italy is seeing increased adoption of ECMO in hospitals as they consider expanding their critical care capacity and incorporating advanced life-support technologies. New training opportunities, awareness campaigns, and established partnerships with ECME globally are key actions driving ECMO in Italy.

Global Extracorporeal Membrane Oxygenation Machine Market By Geography, 2026-2033
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Extracorporeal Membrane Oxygenation Machine Market Dynamics

Extracorporeal Membrane Oxygenation Machine Market Drivers

Increase in the Prevalence of Severe Cardiorespiratory Diseases

  • The increasing incidence of acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and cardiac failure continues to spur the use of ECMO systems across the globe. The increasing prevalence of lifestyle-related cardiovascular diseases has not only added to the prevalence, but it has also caused complications related to serious infections and post-surgical recovery cases eventually resulting in an increased need for ECMO utilization as a life-support modality. The ECMO technology has recently been recognized as an important technology in modern advanced intensive care units, particularly among patients who are not easily managed with standard ventilation or cardiac support, increasing the overall market.

Technological Advancements, and Incorporation of AI

  • Ongoing innovations in ECMO design and development particularly concerning the use of compact consoles, biocompatible materials, and automation monitoring are promoting higher clinical efficiency and safety. The incorporation of artificial intelligence (AI) and the use of machine learning are permitting predictive analytics, automation with flow control, and real-time detection of anomalies. These improvements decrease human error, improve patient management capabilities, and expand ECMO use into emerging and smaller diverse healthcare environments, and these are all important factors for this market growth.

Extracorporeal Membrane Oxygenation Machine Market Restraints

High Cost and Operational Complexity

  • ECMO systems, despite advancements in technology, remain expensive overall both in terms of purchase and maintenance. The need for specific consumables, operating costs, and monitoring 24 hours a day restricts their use to only large tertiary hospitals. The complexity of patient setup, management, and monitoring in ECMO systems necessitates trained personnel, which is a challenge for hospitals with limited financial or workforce expertise.

Limited Reimbursement and Regulatory Barriers

  • ECMO reimbursement, across regions, ranges from limited to specific policies, with many health care systems covering little or delayed reimbursement. Hospitals may be deterred from investing in ECMO programs due to financial uncertainty. Additionally, regulatory standards for approval, operational status, and post-market surveillance limit and slow the timeline for bringing a new product to market, thereby limiting rapid adoption of new technology in some countries.

Request Free Customization of this report to help us to meet your business objectives.

Extracorporeal Membrane Oxygenation Machine Market Competitive Landscape

The extracorporeal membrane oxygenation machine industry features both existing medical device manufacturers and new innovator companies developing more advanced life-support technologies. Existing firms are growing their market position through product innovations, mergers and acquisitions, and increasing their market footprint and globalization. Leading companies such as Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, and Abbott Laboratories dominate the market with established product offerings, wide distribution channels, and integrated solutions for critical care medicine. These key players are investing significantly in research and development to improve the effectiveness, safety, and ease of use of ECMO machines through automation and artificial intelligence.

The market is significant within the advanced life-support and critical care market, providing temporary support for the heart and lungs of people suffering from severe respiratory or cardiac failure. Initially, ECMO technology was designed to be used for patients directly on specialized units in hospitals, and ECMO itself has changed from a large and complicated system to a more efficient, portable, user-friendly device, which has become an important component of the healthcare delivery system. The increasing burden of cardiopulmonary diseases, increased usage of ECMO burst, continued broadening applications across emergency and surgical medicine, and technology advancements resulting in greater safety, monitoring, and treatment precision will propel the market's growth.

  • VQ Biomedical (Established in 2020): VQ Biomedical has been launched as a spinout from Duke University to create a groundbreaking oxygenation system. In 2024 the company raised $5 million to pursue its innovative extracorporeal life support technology, which aims to increase the efficiency and portability of life-support systems and improve the care of patients in critical environments.
  • Eleusô (Established in 2021): Eleusô is a U.S.-based medtech startup developing a hybrid axial ECMO pump that promotes ease and scale of delivery of critical care. Our startup seeks to overcome obstacles to ECMO systems in practice, like operational complexity, dependence on ICU resources, and portability, to improve access to ECMO therapy in a variety of clinical settings.

Top Players in Extracorporeal Membrane Oxygenation Machine Market

  • Medtronic plc
  • Getinge AB
  • LivaNova PLC
  • Terumo Cardiovascular Corporation
  • Nipro Corporation
  • Eurosets S.r.l.
  • Maquet Holding (Getinge Group)
  • CytoSorbents Corporation
  • Medos Medizintechnik AG
  • Microport Scientific Corporation
  • Philips Healthcare (ECLS division)
  • Edwards Lifesciences Corporation
  • Xenios AG
  • Saranas Inc.
  • Oxygen Plus Medical Systems
  • Hemovent GmbH
  • Abiomed Inc.
  • Boston Scientific Corporation
  • Smiths Medical (ICU Life Support Division)
  • Baxter International Inc.

Recent Developments in Extracorporeal Membrane Oxygenation Machine Market

  • In January 2025, Innovative ECMO Concepts announced an expansion of workforce solutions for provider burnout. They now offer total ECMO and perfusion program management, turnkey ECMO program startup, and high census ECMO staffing support. They also offer ECMO education and training with in-person, didactic courses on site, a fully accredited online training program, and high-fidelity simulation.
  • In October 2024, MicroPort acquired Hemovent, a German company specializing in portable ECMO systems. Hemovent's flagship product, the MOBYBOX®, is the first fully integrated ECLS system to manage perfusion and gas exchange in one unit. The acquisition is expected to grow MicroPort's exposure in the extracorporeal life support space.
  • In September 2024, Medtronic announced the VitalFlow™ ECMO System, a configurable, intuitive solution to connect bedside care and intra-hospital transport. The announcement occurred after Medtronic acquired MC3 Cardiopulmonary in March 2024, marking the eighth year of collaboration and the launch of seven new ECMO products over that span.

Extracorporeal Membrane Oxygenation Machine Key Market Trends

Extracorporeal Membrane Oxygenation Machine Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to SkyQuest analysis, the extracorporeal membrane oxygenation machine market is steadily growing, driven by the increasing prevalence of critically ill patients suffering from severe cardiac and respiratory failure. The demand for ECMO systems has been increasing as hospitals enhance their ability to provide critical care, while adopting technologies to provide advanced life support directly to patients. Modern ECMO machines are designed to be smaller, simpler, and digitally connected to allow for better clinical use in adult, pediatric, and neonatal patients. Increasing knowledge about the ability of ECMO to save lives through respiratory crises and other cardiac emergencies has further facilitated the worldwide uptake of ECMO procedures. However, the cost of the machines, maintenance of machinery, and personnel requirements (staffing trained nurses, ECMO specialists, and ICU physicians) can limit the uptake of ECMO-technology in low-resource settings. Sustained innovation with system design, such as AI-based monitoring, automation of ECMO and decision support systems, will bring about smarter procedures to provide ECMO in more efficient and safe ways.

Report Metric Details
Market size value in 2024 USD 328.22 Million
Market size value in 2033 USD 526.9 Million
Growth Rate 5.4%
Base year 2024
Forecast period 2026-2033
Forecast Unit (Value) USD Million
Segments covered
  • Component
    • Pumps ,Oxygenators ,Controllers ,Cannula & Tubing Sets ,Accessories & Consumables
  • Modality
    • Veno-Venous (VV) ,Veno-Arterial (VA) ,Arterio-Venous (AV)
  • Patient Age Group
    • Neonates ,Pediatrics ,Adults
  • Application
    • Respiratory Disorders ,Cardiac Conditions ,Extracorporeal Cardiopulmonary Resuscitation (ECPR)
  • End-User
    • Hospitals (ICU / Cardiac Care Units) ,Specialty Clinics ,Emergency Medical Services
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Medtronic plc
  • Getinge AB
  • LivaNova PLC
  • Terumo Cardiovascular Corporation
  • Nipro Corporation
  • Eurosets S.r.l.
  • Maquet Holding (Getinge Group)
  • CytoSorbents Corporation
  • Medos Medizintechnik AG
  • Microport Scientific Corporation
  • Philips Healthcare (ECLS division)
  • Edwards Lifesciences Corporation
  • Xenios AG
  • Saranas Inc.
  • Oxygen Plus Medical Systems
  • Hemovent GmbH
  • Abiomed Inc.
  • Boston Scientific Corporation
  • Smiths Medical (ICU Life Support Division)
  • Baxter International Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Extracorporeal Membrane Oxygenation Machine Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Extracorporeal Membrane Oxygenation Machine Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Extracorporeal Membrane Oxygenation Machine Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Extracorporeal Membrane Oxygenation Machine Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Extracorporeal Membrane Oxygenation Machine Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Extracorporeal Membrane Oxygenation Machine Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 328.22 Million in 2024 and is poised to grow from USD 345.94 Million in 2025 to USD 526.9 Million by 2033, growing at a CAGR of 5.4% during the forecast period (2026–2033).

The extracorporeal membrane oxygenation machine industry features both existing medical device manufacturers and new innovator companies developing more advanced life-support technologies. Existing firms are growing their market position through product innovations, mergers and acquisitions, and increasing their market footprint and globalization. Leading companies such as Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, and Abbott Laboratories dominate the market with established product offerings, wide distribution channels, and integrated solutions for critical care medicine. These key players are investing significantly in research and development to improve the effectiveness, safety, and ease of use of ECMO machines through automation and artificial intelligence. 'Medtronic plc', 'Getinge AB', 'LivaNova PLC', 'Terumo Cardiovascular Corporation', 'Nipro Corporation', 'Eurosets S.r.l.', 'Maquet Holding (Getinge Group)', 'CytoSorbents Corporation', 'Medos Medizintechnik AG', 'Microport Scientific Corporation', 'Philips Healthcare (ECLS division)', 'Edwards Lifesciences Corporation', 'Xenios AG', 'Saranas Inc.', 'Oxygen Plus Medical Systems', 'Hemovent GmbH', 'Abiomed Inc.', 'Boston Scientific Corporation', 'Smiths Medical (ICU Life Support Division)', 'Baxter International Inc.'

The increasing incidence of acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and cardiac failure continues to spur the use of ECMO systems across the globe. The increasing prevalence of lifestyle-related cardiovascular diseases has not only added to the prevalence, but it has also caused complications related to serious infections and post-surgical recovery cases eventually resulting in an increased need for ECMO utilization as a life-support modality. The ECMO technology has recently been recognized as an important technology in modern advanced intensive care units, particularly among patients who are not easily managed with standard ventilation or cardiac support, increasing the overall market.

Trend Towards Portable and User-Friendly ECMO Systems: Systems manufacturers are developing and marketing small, lightweight, and mobile ECMO machines suitable for use outside of the traditional ICU, including when patients are transported or treated in smaller facilities. These portable ECMO systems typically require less time to set up than more familiar systems, which expands patients' access to ECMO to support therapy, especially in rural and resource-limited settings.

What is the Forecasted Outcome for the Market in North America?
AGC3x.webp
Aisin3x.webp
ASKA P Co. LTD3x.webp
BD3x.webp
BILL & MELIDA3x.webp
BOSCH3x.webp
CHUNGHWA TELECOM3x.webp
DAIKIN3x.webp
DEPARTMENT OF SCIENCE & TECHNOLOGY3x.webp
ETRI3x.webp
Fiti Testing3x.webp
GERRESHEIMER3x.webp
HENKEL3x.webp
HITACHI3x.webp
HOLISTIC MEDICAL CENTRE3x.webp
Institute for information industry3x.webp
JAXA3x.webp
JTI3x.webp
Khidi3x.webp
METHOD.3x.webp
Missul E&S3x.webp
MITSUBISHI3x.webp
MIZUHO3x.webp
NEC3x.webp
Nippon steel3x.webp
NOVARTIS3x.webp
Nttdata3x.webp
OSSTEM3x.webp
PALL3x.webp
Panasonic3x.webp
RECKITT3x.webp
Rohm3x.webp
RR KABEL3x.webp
SAMSUNG ELECTRONICS3x.webp
SEKISUI3x.webp
Sensata3x.webp
SENSEAIR3x.webp
Soft Bank Group3x.webp
SYSMEX3x.webp
TERUMO3x.webp
TOYOTA3x.webp
UNDP3x.webp
Unilever3x.webp
YAMAHA3x.webp
Yokogawa3x.webp

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Feedback From Our Clients